Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,631,948
-
Total 13F shares
-
25,028,008
-
Share change
-
+2,414,409
-
Total reported value
-
$44,548,726
-
Price per share
-
$1.78
-
Number of holders
-
50
-
Value change
-
+$4,459,745
-
Number of buys
-
21
-
Number of sells
-
29
Institutional Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q1 2025
As of 31 Mar 2025,
Vigil Neuroscience, Inc. - Common Stock (VIGL) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,028,008 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, BVF INC/IL, Siren, L.L.C., 683 Capital Management, LLC, Aberdeen Group plc, SPHERA FUNDS MANAGEMENT LTD., Ensign Peak Advisors, Inc, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.